These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 33157291)

  • 1. The benefits and safety of oral sequential antibiotic therapy in non-complicated and complicated Staphylococcus aureus bacteremia.
    Pérez-Rodríguez MT; Sousa A; Moreno-Flores A; Longueira R; Diéguez P; Suárez M; Lima O; Vasallo FJ; Álvarez-Fernández M; Crespo M
    Int J Infect Dis; 2021 Jan; 102():554-560. PubMed ID: 33157291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early oral switch therapy in low-risk Staphylococcus aureus bloodstream infection (SABATO): study protocol for a randomized controlled trial.
    Kaasch AJ; Fätkenheuer G; Prinz-Langenohl R; Paulus U; Hellmich M; Weiß V; Jung N; Rieg S; Kern WV; Seifert H;
    Trials; 2015 Oct; 16():450. PubMed ID: 26452342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of seven and fourteen days of antibiotic treatment in uncomplicated Staphylococcus aureus bacteremia (SAB7): study protocol for a randomized controlled trial.
    Thorlacius-Ussing L; Andersen CØ; Frimodt-Møller N; Knudsen IJD; Lundgren J; Benfield TL
    Trials; 2019 May; 20(1):250. PubMed ID: 31046810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequential oral antibiotic in uncomplicated Staphylococcus aureus bacteraemia: a propensity-matched cohort analysis.
    Diego-Yagüe I; Mora-Vargas A; Vázquez-Comendador JM; Santamarina-Alcantud B; Fernández-Cruz A; Múñez-Rubio E; Gutiérrez-Villanueva A; Sanchez-Romero I; Moreno-Torres V; Ramos-Martínez A; Calderón-Parra J
    Clin Microbiol Infect; 2023 Jun; 29(6):744-750. PubMed ID: 36773773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between treatment duration and mortality or relapse in adult patients with Staphylococcus aureus bacteraemia: a retrospective cohort study.
    Abbas M; Rossel A; de Kraker MEA; von Dach E; Marti C; Emonet S; Harbarth S; Kaiser L; Uçkay I
    Clin Microbiol Infect; 2020 May; 26(5):626-631. PubMed ID: 31357013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early Oral Switch to Linezolid for Low-risk Patients With Staphylococcus aureus Bloodstream Infections: A Propensity-matched Cohort Study.
    Willekens R; Puig-Asensio M; Ruiz-Camps I; Larrosa MN; González-López JJ; Rodríguez-Pardo D; Fernández-Hidalgo N; Pigrau C; Almirante B
    Clin Infect Dis; 2019 Jul; 69(3):381-387. PubMed ID: 30351401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Automated, Pharmacist-Driven Initiative Improves Quality of Care for Staphylococcus aureus Bacteremia.
    Wenzler E; Wang F; Goff DA; Prier B; Mellett J; Mangino JE; Bauer KA
    Clin Infect Dis; 2017 Jul; 65(2):194-200. PubMed ID: 28379326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adequacy of antimicrobial treatment and outcome of Staphylococcus aureus bacteremia in 9 Western European countries.
    Ammerlaan H; Seifert H; Harbarth S; Brun-Buisson C; Torres A; Antonelli M; Kluytmans J; Bonten M;
    Clin Infect Dis; 2009 Oct; 49(7):997-1005. PubMed ID: 19719417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early Oral Antibiotic Switch in Staphylococcus aureus Bacteraemia: The Staphylococcus aureus Network Adaptive Platform (SNAP) Trial Early Oral Switch Protocol.
    de Kretser D; Mora J; Bloomfield M; Campbell A; Cheng MP; Guy S; Hensgens M; Kalimuddin S; Lee TC; Legg A; Mahar RK; Marks M; Marsh J; McGlothin A; Morpeth SC; Sud A; Ten Oever J; Yahav D; Bonten M; Bowen AC; Daneman N; van Hal SJ; Heriot GS; Lewis RJ; Lye DC; McQuilten Z; Paterson DL; Owen Robinson J; Roberts JA; Scarborough M; Webb SA; Whiteway L; Tong SYC; Davis JS; Walls G; Goodman AL; ;
    Clin Infect Dis; 2024 Oct; 79(4):871-887. PubMed ID: 37921609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Staphylococcus aureus bacteraemia--Nationwide assessment of treatment adequacy and outcome.
    Asgeirsson H; Kristjansson M; Kristinsson KG; Gudlaugsson O
    J Infect; 2011 May; 62(5):339-46. PubMed ID: 21402101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment duration for uncomplicated Staphylococcus aureus bacteremia to prevent relapse: analysis of a prospective observational cohort study.
    Chong YP; Moon SM; Bang KM; Park HJ; Park SY; Kim MN; Park KH; Kim SH; Lee SO; Choi SH; Jeong JY; Woo JH; Kim YS
    Antimicrob Agents Chemother; 2013 Mar; 57(3):1150-6. PubMed ID: 23254436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Staphylococcus aureus - selective reporting of antibiogram results and its impact on antibiotic use: Interventional study with a reference group on the effect of switching from non-selective to selective antibiotic reporting.
    Lestin-Bernstein F; Harberg R; Schumacher I; Briedigkeit L; Heese O; Biedermann K
    Antimicrob Resist Infect Control; 2021 Nov; 10(1):157. PubMed ID: 34742320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retrospective study to investigate appropriate duration of antibiotic treatment for uncomplicated Staphylococcus aureus bacteremia in patients with immunodeficiency.
    Shibata Y; Asai N; Hirai J; Mori N; Hagihara M; Mikamo H
    J Infect Chemother; 2024 Nov; 30(11):1141-1146. PubMed ID: 38729565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mortality predictors of Staphylococcus aureus bacteremia: a prospective multicenter study.
    Yilmaz M; Elaldi N; Balkan İİ; Arslan F; Batırel AA; Bakıcı MZ; Gozel MG; Alkan S; Çelik AD; Yetkin MA; Bodur H; Sınırtaş M; Akalın H; Altay FA; Şencan İ; Azak E; Gündeş S; Ceylan B; Öztürk R; Leblebicioglu H; Vahaboglu H; Mert A
    Ann Clin Microbiol Antimicrob; 2016 Feb; 15():7. PubMed ID: 26860463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of a pharmacist-driven care package on Staphylococcus aureus bacteremia management in a large community healthcare network: A propensity score-matched, quasi-experimental study.
    Smith JR; Frens JJ; Snider CB; Claeys KC
    Diagn Microbiol Infect Dis; 2018 Jan; 90(1):50-54. PubMed ID: 29153470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Healthcare Improvement Intervention Combining Nucleic Acid Microarray Testing With Direct Physician Response for Management of Staphylococcus aureus Bacteremia.
    Eby JC; Richey MM; Platts-Mills JA; Mathers AJ; Novicoff WM; Cox HL
    Clin Infect Dis; 2018 Jan; 66(1):64-71. PubMed ID: 29020181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction of 30-day death rates from Staphylococcus aureus bacteremia by mandatory infectious diseases consultation: Comparative study interventions with and without an infectious disease specialist.
    Hadano Y; Kakuma T; Matsumoto T; Ishibashi K; Isoda M; Yasunaga H
    Int J Infect Dis; 2021 Feb; 103():308-315. PubMed ID: 33278619
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Berrevoets MAH; Kouijzer IJE; Slieker K; Aarntzen EHJG; Kullberg BJ; Oever JT; Bleeker-Rovers CP
    J Nucl Med; 2019 Jul; 60(7):998-1002. PubMed ID: 30552202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vancomycin MIC Does Not Predict 90-Day Mortality, Readmission, or Recurrence in a Prospective Cohort of Adults with Staphylococcus aureus Bacteremia.
    Baxi SM; Clemenzi-Allen A; Gahbauer A; Deck D; Imp B; Vittinghoff E; Chambers HF; Doernberg S
    Antimicrob Agents Chemother; 2016 Sep; 60(9):5276-84. PubMed ID: 27324762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of infective endocarditis and complicated infection in Staphylococcus aureus bacteremia - a retrospective cohort study on the role of bacteriuria.
    Bergenman O; Nilson B; Rasmussen M
    Eur J Clin Microbiol Infect Dis; 2024 Jul; 43(7):1419-1426. PubMed ID: 38771404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.